Merck overturns APECS Study assessing Verubecestat (MK-8931) for Prodromal Alzheimer’s Disease Read more
Sanofi announces new safety data for investigational avalglucosidase alfa in patients with Pompe disease Read more
Bavarian Nordic announces positive results of Pivotal Phase 3 Study of IMVAMUNE smallpox vaccine Read more